Michael J. Fisher, MD, is chief of the Section of Neuro-Oncology in the Cancer Center at The Children's Hospital of Philadelphia and director of the Neuro-Oncology Fellowship Program. He has a special interest in brain tumors and neurofibromatosis. After graduating from Harvard Medical School, he did his pediatric training at Children's Hospital in Boston. He then did fellowships in pediatric hematology/oncology and pediatric neuro-oncology at CHOP, and has been on staff at CHOP since that time.
His research focuses on identifying new treatments and novel biomarkers (particularly using new imaging modalities) and exploring functional outcomes for children with tumors associated with NF1 and for brain tumors.
Dr. Fisher is a member of the CNS Tumor Committee of the Children's Oncology Group and Co-Principal Investigator (PI) of CHOP for the Pacific Pediatric NeuroOncology Consortium. He has extensive experience in developing, leading and conducting therapeutic clinical trials, observational studies and retrospective studies for children with nervous system tumors. He is Deputy Chair of the NF Clinical Trials Consortium. He is Chair of the Visual Outcomes Committee and member of the Steering Committee for REiNS (Response Evaluation in Neurofibromatosis and Schwannomatosis), an international effort to develop standardized outcome measures for clinical trials. In addition, Dr. Fisher serves as co-leader of a large, international, multi-institutional, prospective longitudinal study of patients with newly diagnosed NF1-associated optic pathway glioma, and is co-PI of a project to identify molecular risk factors and treatments for NF1-low grade glioma.
We are grateful to these advisors for helping No More Kids with Cancer and children everywhere.